Literature DB >> 1702764

Analysis of Pseudomonas exotoxin activation and conformational changes by using monoclonal antibodies as probes.

M Ogata1, I Pastan, D FitzGerald.   

Abstract

Pseudomonas exotoxin (PE) is a protein toxin composed of three structural domains. In its native form, the toxin is a 66,000-Mr proenzyme that must be activated to express full ADP-ribosylating activity. To study the process of activation and accompanying conformational changes, we have isolated 10 monoclonal antibodies to a 40,000-Mr fragment of the toxin (PE40) that exhibits full enzyme activity but lacks the toxin's cell-binding domain and contains amino acids 253 to 613 (comprising domains II, Ib, and III). By using mutant PE molecules in which all of domain I and portions of domains II, Ib, and III were deleted, the locations of the epitopes for each of the antibodies were determined. Eight of these monoclonal antibodies were further characterized. Of these eight, all reacted with soluble PE40 and an interleukin-2-PE40 conjugate, but only two reacted strongly with native soluble PE. However, all eight reacted with PE after it had been immobilized on nitrocellulose or after it had been activated to express full ADP-ribosylating activity. Antibodies were also assessed for their ability to neutralize the cytotoxic activity of either PE or interleukin-2-PE40. These antibodies should be useful as probes for monitoring the activation and processing of PE that occur during endocytosis and in determining the location of epitopes that are important for toxin activity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1702764      PMCID: PMC257755          DOI: 10.1128/iai.59.1.407-414.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.609


  26 in total

Review 1.  Targeted toxin therapy for the treatment of cancer.

Authors:  D FitzGerald; I Pastan
Journal:  J Natl Cancer Inst       Date:  1989-10-04       Impact factor: 13.506

2.  Pseudomonas aeruginosa immunotype 5 polysaccharide-toxin A conjugate vaccine.

Authors:  S J Cryz; E Furer; J C Sadoff; R Germanier
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Cytotoxic activity of an interleukin 2-Pseudomonas exotoxin chimeric protein produced in Escherichia coli.

Authors:  H Lorberboum-Galski; D FitzGerald; V Chaudhary; S Adhya; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

5.  Processing of Pseudomonas exotoxin by a cellular protease results in the generation of a 37,000-Da toxin fragment that is translocated to the cytosol.

Authors:  M Ogata; V K Chaudhary; I Pastan; D J FitzGerald
Journal:  J Biol Chem       Date:  1990-11-25       Impact factor: 5.486

6.  Structure of exotoxin A of Pseudomonas aeruginosa at 3.0-Angstrom resolution.

Authors:  V S Allured; R J Collier; S F Carroll; D B McKay
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 12.779

7.  Pseudomonas aeruginosa: biology, mechanisms of virulence, epidemiology.

Authors:  M L Vasil
Journal:  J Pediatr       Date:  1986-05       Impact factor: 6.314

8.  Activity of immunotoxins constructed with modified Pseudomonas exotoxin A lacking the cell recognition domain.

Authors:  T Kondo; D FitzGerald; V K Chaudhary; S Adhya; I Pastan
Journal:  J Biol Chem       Date:  1988-07-05       Impact factor: 5.486

9.  Pseudomonas toxin binds triton X-114 at low pH.

Authors:  K Sandvig; J O Moskaug
Journal:  Biochem J       Date:  1987-08-01       Impact factor: 3.766

10.  Functional domains of Pseudomonas exotoxin identified by deletion analysis of the gene expressed in E. coli.

Authors:  J Hwang; D J Fitzgerald; S Adhya; I Pastan
Journal:  Cell       Date:  1987-01-16       Impact factor: 66.850

View more
  12 in total

1.  Structure-function analyses of diphtheria toxin by use of monoclonal antibodies.

Authors:  J M Rolf; L Eidels
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

2.  Whole-genome RNAi screen highlights components of the endoplasmic reticulum/Golgi as a source of resistance to immunotoxin-mediated cytotoxicity.

Authors:  Matteo Pasetto; Antonella Antignani; Pinar Ormanoglu; Eugen Buehler; Rajarshi Guha; Ira Pastan; Scott E Martin; David J FitzGerald
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-23       Impact factor: 11.205

3.  Initial characterization of an immunotoxin constructed from domains II and III of cholera exotoxin.

Authors:  Robert Sarnovsky; Tara Tendler; Matheusz Makowski; Maureen Kiley; Antonella Antignani; Roberta Traini; Jingli Zhang; Raffit Hassan; David J FitzGerald
Journal:  Cancer Immunol Immunother       Date:  2009-11-29       Impact factor: 6.968

4.  ABT-737 promotes the dislocation of ER luminal proteins to the cytosol, including pseudomonas exotoxin.

Authors:  Antonella Antignani; Robert Sarnovsky; David J FitzGerald
Journal:  Mol Cancer Ther       Date:  2014-04-16       Impact factor: 6.261

5.  Characterization of a cellular protease that cleaves Pseudomonas exotoxin.

Authors:  C Fryling; M Ogata; D FitzGerald
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.609

6.  Primate antibody response to immunotoxin: serological and computer-aided analysis of epitopes on a truncated form of Pseudomonas exotoxin.

Authors:  D M Roscoe; S H Jung; I Benhar; L Pai; B K Lee; I Pastan
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.609

7.  Generation of antibody-based therapeutics targeting the Idiotype of B-cell Malignancies.

Authors:  Emily Weiss; Robert Sarnovsky; Mitchell Ho; Evgeny Arons; Robert Kreitman; Evan Angelus; Antonella Antignani; David FitzGerald
Journal:  Antib Ther       Date:  2018-12-27

8.  Binding of monoclonal antibody specific for domain Ia/II of Pseudomonas aeruginosa exotoxin A at pH 4 strongly neutralizes exotoxin A-induced cytotoxicity in cell culture and in vivo.

Authors:  H Ohtsuka; K Horigome; A Higuchi; N Nomura; H Ochi; S Yokota; T Kohzuki; H Noguchi
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.609

9.  Targeting a Cancer-Specific Epitope of the Epidermal Growth Factor Receptor in Triple-Negative Breast Cancer.

Authors:  Nathan Simon; Antonella Antignani; Robert Sarnovsky; Stephen M Hewitt; David FitzGerald
Journal:  J Natl Cancer Inst       Date:  2016-04-13       Impact factor: 11.816

10.  Protection against exotoxin A (ETA) and Pseudomonas aeruginosa infection in mice with ETA-specific antipeptide antibodies.

Authors:  H S El-Zaim; A K Chopra; J W Peterson; M L Vasil; J P Heggers
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.